china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214).
.
.
.
.
.
.
.
.
.
by continuing to use this site you consent to the use of cookies on your device as described in our
.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
.
.